Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Accidental acetylcysteine poisoning |
Causative agent (attribute) |
False |
Acetylcysteine (substance) |
Inferred relationship |
Some |
|
Intentional acetylcysteine poisoning |
Causative agent (attribute) |
False |
Acetylcysteine (substance) |
Inferred relationship |
Some |
|
intoxication par l'acétylcystéine d'intention indéterminée |
Causative agent (attribute) |
False |
Acetylcysteine (substance) |
Inferred relationship |
Some |
1 |
Acetylcysteine adverse reaction |
Causative agent (attribute) |
True |
Acetylcysteine (substance) |
Inferred relationship |
Some |
1 |
Allergy to acetylcysteine (finding) |
Causative agent (attribute) |
False |
Acetylcysteine (substance) |
Inferred relationship |
Some |
|
Acetylcysteine overdose |
Causative agent (attribute) |
True |
Acetylcysteine (substance) |
Inferred relationship |
Some |
1 |
Accidental acetylcysteine overdose |
Causative agent (attribute) |
True |
Acetylcysteine (substance) |
Inferred relationship |
Some |
1 |
Intentional acetylcysteine overdose |
Causative agent (attribute) |
True |
Acetylcysteine (substance) |
Inferred relationship |
Some |
1 |
surdose d'acétylcystéine d'intention indéterminée |
Causative agent (attribute) |
False |
Acetylcysteine (substance) |
Inferred relationship |
Some |
1 |
Acetylcysteine [respiratory use] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Acetylcysteine (substance) |
Inferred relationship |
Some |
|
Acetylcysteine [paracetamol poisoning treatment] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Acetylcysteine (substance) |
Inferred relationship |
Some |
|
acétylcystéine 200 mg/mL, ampoule de 10 mL pour perfusion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Acetylcysteine (substance) |
Inferred relationship |
Some |
|
Acetylcysteine [eyes] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Acetylcysteine (substance) |
Inferred relationship |
Some |
|
Acetylcysteine 50 mg/mL eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Acetylcysteine (substance) |
Inferred relationship |
Some |
|
Acetylcysteine 5% preservative-free eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Acetylcysteine (substance) |
Inferred relationship |
Some |
|
Acetylcysteine 100 mg/mL eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Acetylcysteine (substance) |
Inferred relationship |
Some |
|
Acetylcysteine 10% preservative-free eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Acetylcysteine (substance) |
Inferred relationship |
Some |
|
Acetylcysteine 200 mg/mL eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Acetylcysteine (substance) |
Inferred relationship |
Some |
|
Acetylcysteine 200 mg/mL solution for inhalation |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Acetylcysteine (substance) |
Inferred relationship |
Some |
|
Acetylcysteine 100 mg/mL solution for inhalation |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Acetylcysteine (substance) |
Inferred relationship |
Some |
|
Product containing acetylcysteine in ocular dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Acetylcysteine (substance) |
Inferred relationship |
Some |
1 |
Poisoning by acetylcysteine |
Causative agent (attribute) |
True |
Acetylcysteine (substance) |
Inferred relationship |
Some |
1 |
Product containing acetylcysteine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Acetylcysteine (substance) |
Inferred relationship |
Some |
1 |
Acetylcysteine 20% injection solution 30mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Acetylcysteine (substance) |
Inferred relationship |
Some |
|
Accidental acetylcysteine poisoning |
Causative agent (attribute) |
True |
Acetylcysteine (substance) |
Inferred relationship |
Some |
1 |
Intentional acetylcysteine poisoning |
Causative agent (attribute) |
True |
Acetylcysteine (substance) |
Inferred relationship |
Some |
1 |
Acetylcysteine 600 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Acetylcysteine (substance) |
Inferred relationship |
Some |
|
Product containing acetylcysteine in respiratory dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Acetylcysteine (substance) |
Inferred relationship |
Some |
|
Acetylcysteine-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Acetylcysteine (substance) |
Inferred relationship |
Some |
1 |
Acetylcysteine-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Acetylcysteine (substance) |
Inferred relationship |
Some |
1 |
Allergy to acetylcysteine (finding) |
Causative agent (attribute) |
True |
Acetylcysteine (substance) |
Inferred relationship |
Some |
1 |
Acetylcysteine 600 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Acetylcysteine (substance) |
Inferred relationship |
Some |
1 |
Acetylcysteine 600 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Acetylcysteine (substance) |
Inferred relationship |
Some |
1 |
Acetylcysteine 600 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Acetylcysteine (substance) |
Inferred relationship |
Some |
1 |
Acetylcysteine 50 mg/mL eye drops |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Acetylcysteine (substance) |
Inferred relationship |
Some |
1 |
Acetylcysteine 50 mg/mL eye drops |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Acetylcysteine (substance) |
Inferred relationship |
Some |
1 |
Acetylcysteine 100 mg/mL eye drops |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Acetylcysteine (substance) |
Inferred relationship |
Some |
1 |
Acetylcysteine 100 mg/mL eye drops |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Acetylcysteine (substance) |
Inferred relationship |
Some |
1 |
Acetylcysteine 200 mg/mL eye drops |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Acetylcysteine (substance) |
Inferred relationship |
Some |
1 |
Acetylcysteine 200 mg/mL eye drops |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Acetylcysteine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely acetylcysteine 2 gram/10 milliliter conventional release solution for infusion ampule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Acetylcysteine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely acetylcysteine 2 gram/10 milliliter conventional release solution for infusion ampule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Acetylcysteine (substance) |
Inferred relationship |
Some |
1 |
Acetylcysteine-containing product in pulmonary dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Acetylcysteine (substance) |
Inferred relationship |
Some |
1 |
Product containing only acetylcysteine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Acetylcysteine (substance) |
Inferred relationship |
Some |
1 |
Product containing only acetylcysteine in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Acetylcysteine (substance) |
Inferred relationship |
Some |
1 |
Product containing only acetylcysteine in ocular dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Acetylcysteine (substance) |
Inferred relationship |
Some |
1 |
Acetylcysteine only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Acetylcysteine (substance) |
Inferred relationship |
Some |
1 |
Product containing only acetylcysteine in pulmonary dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Acetylcysteine (substance) |
Inferred relationship |
Some |
1 |
Acetylcysteine 200 mg/mL solution for infusion |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Acetylcysteine (substance) |
Inferred relationship |
Some |
1 |
Acetylcysteine 200 mg/mL solution for infusion |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Acetylcysteine (substance) |
Inferred relationship |
Some |
1 |
Acetylcysteine 200 mg/mL solution for inhalation |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Acetylcysteine (substance) |
Inferred relationship |
Some |
1 |
Acetylcysteine 200 mg/mL solution for inhalation |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Acetylcysteine (substance) |
Inferred relationship |
Some |
1 |
Acetylcysteine 100 mg/mL solution for inhalation |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Acetylcysteine (substance) |
Inferred relationship |
Some |
1 |
Acetylcysteine 100 mg/mL solution for inhalation |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Acetylcysteine (substance) |
Inferred relationship |
Some |
1 |
Acetylcysteine 600 mg effervescent oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Acetylcysteine (substance) |
Inferred relationship |
Some |
1 |
Acetylcysteine 600 mg effervescent oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Acetylcysteine (substance) |
Inferred relationship |
Some |
1 |
Acetylcysteine 200 mg/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Acetylcysteine (substance) |
Inferred relationship |
Some |
1 |
Acetylcysteine 200 mg/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Acetylcysteine (substance) |
Inferred relationship |
Some |
1 |
Acetylcysteine 300 mg and ambroxol hydrochloride 30 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Acetylcysteine (substance) |
Inferred relationship |
Some |
1 |
Acetylcysteine 300 mg and ambroxol hydrochloride 30 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Acetylcysteine (substance) |
Inferred relationship |
Some |
1 |
Product containing acetylcysteine and ambroxol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Acetylcysteine (substance) |
Inferred relationship |
Some |
1 |
Acetylcysteine and ambroxol only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Acetylcysteine (substance) |
Inferred relationship |
Some |
1 |
Product containing only acetylcysteine and ambroxol in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Acetylcysteine (substance) |
Inferred relationship |
Some |
1 |
Product containing acetylcysteine and ambroxol in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Acetylcysteine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely acetylcysteine 150 milligram and taurine 500 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Acetylcysteine (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely acetylcysteine 150 milligram and taurine 500 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Acetylcysteine (substance) |
Inferred relationship |
Some |
2 |
Acetylcysteine- and taurine-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Acetylcysteine (substance) |
Inferred relationship |
Some |
2 |
Product containing only acetylcysteine and taurine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Acetylcysteine (substance) |
Inferred relationship |
Some |
2 |
Acetylcysteine- and taurine-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Acetylcysteine (substance) |
Inferred relationship |
Some |
2 |
Acetylcysteine and taurine only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Acetylcysteine (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely acetylcysteine 200 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Acetylcysteine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely acetylcysteine 200 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Acetylcysteine (substance) |
Inferred relationship |
Some |
1 |